Abdoh Q, Kittaneh A, Rabi R, Dweikat A, Darwish A, Najajra D, Awwad M, Rajab I, Yaghmour R, Alnees M. Risk factors for anti-infliximab antibody formation among patients with inflammatory bowel disease. MedNEXT J Med Health Sci [Internet]. 2024 Jul. 31 [cited 2025 Apr. 22];5(3). Available from: https://mednext.zotarellifilhoscientificworks.com/index.php/mednext/article/view/387